Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
Cipla
Fuji
UBS
Farmers Insurance
Cerilliant
McKinsey
Express Scripts
Boehringer Ingelheim

Generated: February 19, 2018

DrugPatentWatch Database Preview

Wyeth Pharms Company Profile

« Back to Dashboard

Summary for Wyeth Pharms
International Patents:239
US Patents:18
Tradenames:35
Ingredients:21
NDAs:37

Drugs and US Patents for Wyeth Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc CORDARONE amiodarone hydrochloride TABLET;ORAL 018972-001 Dec 24, 1985 DISCN Yes No ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc ZOSYN piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050684-001 Oct 22, 1993 AP RX Yes Yes 8,133,883 ➤ Sign Up Y ➤ Sign Up
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-001 Dec 28, 1993 DISCN Yes No ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc LEVONORGESTREL levonorgestrel IMPLANT;IMPLANTATION 020627-001 Aug 15, 1996 DISCN No No ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc EFFEXOR XR venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020699-002 Oct 20, 1997 AB RX Yes No ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc INDERAL propranolol hydrochloride TABLET;ORAL 016418-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-003 Feb 24, 1998 RX Yes Yes 7,915,229 ➤ Sign Up Y ➤ Sign Up
Wyeth Pharms Inc PREMPHASE 14/14 estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-002 Nov 17, 1995 RX Yes Yes ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc PIPRACIL piperacillin sodium INJECTABLE;INJECTION 050545-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc PHOSPHOLINE IODIDE echothiophate iodide FOR SOLUTION;OPHTHALMIC 011963-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Wyeth Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc PREMPHASE 14/14 estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-002 Nov 17, 1995 5,547,948 ➤ Sign Up
Wyeth Pharms Pfizer DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 7,138,392 ➤ Sign Up
Wyeth Pharms Inc PREMPRO estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-003 Jan 9, 1998 4,826,831 ➤ Sign Up
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-003 Dec 28, 1993 4,535,186*PED ➤ Sign Up
Wyeth Pharms Inc PROTONIX IV pantoprazole sodium INJECTABLE;IV (INFUSION) 020988-001 Mar 22, 2001 4,758,579*PED ➤ Sign Up
Wyeth Pharms Inc PREMARIN estrogens, conjugated TABLET;ORAL 004782-002 Approved Prior to Jan 1, 1982 5,210,081 ➤ Sign Up
Wyeth Pharms Inc PREMARIN estrogens, conjugated TABLET;ORAL 004782-005 Jan 26, 1984 5,210,081 ➤ Sign Up
Wyeth Pharms Inc EFFEXOR XR venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020699-002 Oct 20, 1997 6,419,958*PED ➤ Sign Up
Wyeth Pharms Inc MYLOTARG gemtuzumab ozogamicin INJECTABLE;INJECTION 021174-001 May 17, 2000 5,606,040 ➤ Sign Up
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-002 Dec 28, 1993 6,274,171 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for WYETH PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Tablets 25 mg ➤ Subscribe 5/8/2015
➤ Subscribe Extended-release Tablets 50 mg and 100 mg ➤ Subscribe 2/29/2012
➤ Subscribe For Injection 12 g/1.5 g per vial (pharmacy bulk) ➤ Subscribe 12/6/2011
➤ Subscribe Tablets 0.09 mg/0.02 mg ➤ Subscribe 10/5/2007
➤ Subscribe Extended-release Tablets 37.5 mg, 75 mg and 150 mg ➤ Subscribe 5/3/2007
➤ Subscribe Tablets 25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg ➤ Subscribe 11/3/2005
➤ Subscribe Delayed-release Tablets 20 mg and 40 mg ➤ Subscribe 2/2/2004

Non-Orange Book US Patents for Wyeth Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,449,455 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents ➤ Sign Up
6,127,404 Tissue selective compounds in the treatment of endometrial proliferation ➤ Sign Up
6,291,451 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents ➤ Sign Up
6,951,852 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indoles as estrogenic agents ➤ Sign Up
7,247,624 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents ➤ Sign Up
6,326,367 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents ➤ Sign Up
6,835,729 2-phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents ➤ Sign Up
7,041,663 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents ➤ Sign Up
6,924,281 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents ➤ Sign Up
6,787,538 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Wyeth Pharms Drugs

Supplementary Protection Certificates for Wyeth Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0030 France ➤ Sign Up PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607
2011 00026 Denmark ➤ Sign Up PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216
49/2008 Austria ➤ Sign Up PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON
0802183/01 Switzerland ➤ Sign Up PRODUCT NAME: BAZEDOXIFEN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58732 12.01.2010
1214076/01 Switzerland ➤ Sign Up PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008
13/055 Ireland ➤ Sign Up PRODUCT NAME: THE COMBINATION OF: (A) DEXTROMETHORPHAN OR A PHARMACEUTICALLY ACCEPTABLE SALT, PRECURSOR OR DERIVATIVE THEREOF, E.G. DEXTROMETHORPHAN HYDROBROMIDE AND IN PARTICULAR DEXTROMETHORPHAN HYDROBROMIDE MONOHYDRATE; AND (B) QUINIDINE OR A PHARMACEUTICALLY ACCEPTABLE SALT, PRECURSOR OR DERIVATIVE THEREOF, E.G. QUINIDINE SULPHATE AND IN PARTICULAR QUINIDINE SULPHATE DIHYDRATE, PROTECTED BY THE BASIC PATENT; REGISTRATION NO/DATE: EU/1/13/833 20130624
09/028 Ireland ➤ Sign Up PRODUCT NAME: BAZEDOXIFENE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTRATION NO/DATE: EU/1/09/511/001-004 20090417
2009007 Lithuania ➤ Sign Up PRODUCT NAME: BAZEDOXIFENUM; REGISTRATION NO/DATE: EU/1/09/511/001 - EU/1/09/511/004 20090417
C0032 Belgium ➤ Sign Up PRODUCT NAME: PANTOPRAZOL. NATR. SESQUIHYDRAS PANTOPRAZOLE; NAT. REGISTRATION NO/DATE: 127 IS 98 F 3 19960222; FIRST REGISTRATION: SE 12131 19940506
2009007,C0802183 Lithuania ➤ Sign Up PRODUCT NAME: BAZEDOXIFENUM; REGISTRATION NO/DATE: EU/1/09/511/001 - EU/1/09/511/004 20090417
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
US Department of Justice
Daiichi Sankyo
Johnson and Johnson
Cipla
McKesson
Healthtrust
Cerilliant
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot